Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Receivables - Accured (2023 - 2024)

Historic Receivables - Accured for Roivant Sciences (ROIV) over the last 2 years, with Q4 2024 value amounting to $23.2 million.

  • Roivant Sciences' Receivables - Accured rose 2268.13% to $23.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $23.2 million, marking a year-over-year increase of 2268.13%. This contributed to the annual value of $23.2 million for FY2024, which is 2268.13% up from last year.
  • Latest data reveals that Roivant Sciences reported Receivables - Accured of $23.2 million as of Q4 2024, which was up 2268.13% from $13.9 million recorded in Q3 2024.
  • Roivant Sciences' 5-year Receivables - Accured high stood at $27.4 million for Q1 2024, and its period low was $4.9 million during Q1 2023.